Home/Filings/4/0001127602-24-029592
4//SEC Filing

Stonehouse Jon P 4

Accession 0001127602-24-029592

CIK 0000882796other

Filed

Dec 16, 7:00 PM ET

Accepted

Dec 17, 4:16 PM ET

Size

6.2 KB

Accession

0001127602-24-029592

Insider Transaction Report

Form 4
Period: 2024-12-14
Stonehouse Jon P
DirectorPresident & CEO
Transactions
  • Tax Payment

    Common Stock

    2024-12-14$7.53/sh27,525$207,2631,101,019 total
Holdings
  • Common Stock

    (indirect: By Trust)
    20,000
  • Common Stock

    (indirect: By Trust)
    20,000
Footnotes (1)
  • [F1]Represents shares withheld by the Issuer to satisfy required tax withholding obligations in connection with the vesting of previously granted Restricted Stock Units. This transaction does not represent a sale by the Reporting Person.

Issuer

BIOCRYST PHARMACEUTICALS INC

CIK 0000882796

Entity typeother

Related Parties

1
  • filerCIK 0001385496

Filing Metadata

Form type
4
Filed
Dec 16, 7:00 PM ET
Accepted
Dec 17, 4:16 PM ET
Size
6.2 KB